Cas no 1803728-57-5 (2,5-Dichloropyrimidine-4-carbaldehyde)
2,5-Dichloropyrimidine-4-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- ClC1=NC=C(C(=N1)C=O)Cl
- 2,5-Dichloropyrimidine-4-carbaldehyde
- 2,5-Dichloropyrimidine-4-carboxaldehyde
-
- Inchi: 1S/C5H2Cl2N2O/c6-3-1-8-5(7)9-4(3)2-10/h1-2H
- InChI Key: ZKGNWHVEBSQCKK-UHFFFAOYSA-N
- SMILES: ClC1=CN=C(N=C1C=O)Cl
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 133
- XLogP3: 1.6
- Topological Polar Surface Area: 42.8
2,5-Dichloropyrimidine-4-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A039001674-250mg |
2,5-Dichloropyrimidine-4-carboxaldehyde |
1803728-57-5 | 98% | 250mg |
$776.06 | 2022-04-02 | |
| Alichem | A039001674-500mg |
2,5-Dichloropyrimidine-4-carboxaldehyde |
1803728-57-5 | 98% | 500mg |
$1,130.22 | 2022-04-02 | |
| Alichem | A039001674-1g |
2,5-Dichloropyrimidine-4-carboxaldehyde |
1803728-57-5 | 98% | 1g |
$2,226.68 | 2022-04-02 |
2,5-Dichloropyrimidine-4-carbaldehyde Related Literature
-
J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
Additional information on 2,5-Dichloropyrimidine-4-carbaldehyde
2,5-Dichloropyrimidine-4-carbaldehyde (CAS No. 1803728-57-5): An Overview of Its Synthesis, Properties, and Applications
2,5-Dichloropyrimidine-4-carbaldehyde (CAS No. 1803728-57-5) is a versatile compound that has garnered significant attention in the fields of organic synthesis, medicinal chemistry, and pharmaceutical research. This compound is characterized by its unique chemical structure, which includes a pyrimidine ring substituted with two chlorine atoms and a carbonyl group at the 4-position. The combination of these functional groups imparts distinct chemical properties and reactivity, making it a valuable intermediate in the synthesis of various biologically active molecules.
The synthesis of 2,5-dichloropyrimidine-4-carbaldehyde has been extensively studied due to its importance as a building block in the development of novel drugs and chemical probes. One common synthetic route involves the condensation of 2,5-dichloropyrimidine with an appropriate aldehyde or ketone followed by oxidation to form the aldehyde. This process can be optimized using various catalysts and solvents to achieve high yields and purity.
Recent advancements in synthetic methodologies have further enhanced the efficiency and scalability of producing 2,5-dichloropyrimidine-4-carbaldehyde. For instance, a study published in the Journal of Organic Chemistry in 2021 reported a novel one-pot synthesis method that significantly reduced reaction time and improved yield. The use of green solvents and environmentally friendly catalysts has also been explored to minimize the environmental impact of the synthesis process.
The physical and chemical properties of 2,5-dichloropyrimidine-4-carbaldehyde are crucial for understanding its behavior in various chemical reactions and applications. This compound is typically a white crystalline solid with a melting point ranging from 110°C to 115°C. It is soluble in common organic solvents such as dimethyl sulfoxide (DMSO), dimethylformamide (DMF), and acetone but exhibits limited solubility in water. The presence of the carbonyl group makes it reactive towards nucleophiles, while the chlorine atoms provide electrophilic character, enabling a wide range of substitution reactions.
In medicinal chemistry, 2,5-dichloropyrimidine-4-carbaldehyde has shown promise as a key intermediate in the synthesis of antiviral agents, anticancer drugs, and other therapeutic molecules. Its ability to form stable complexes with metal ions has also been exploited in the development of metal-based drugs. For example, a recent study published in Bioorganic & Medicinal Chemistry Letters demonstrated that derivatives of 2,5-dichloropyrimidine-4-carbaldehyde exhibited potent antiviral activity against several RNA viruses, including influenza A virus and respiratory syncytial virus (RSV).
The biological activity of compounds derived from 2,5-dichloropyrimidine-4-carbaldehyde has been extensively investigated through various in vitro and in vivo studies. These studies have revealed that these derivatives can modulate key cellular processes such as protein kinase activity, DNA replication, and cell cycle progression. For instance, a derivative featuring an additional hydroxyl group at the 6-position showed significant inhibition of cyclin-dependent kinases (CDKs), which are important targets for cancer therapy.
Beyond its medicinal applications, 2,5-dichloropyrimidine-4-carbaldehyde has found utility in other areas of chemical research. In materials science, it has been used as a precursor for the synthesis of functional polymers with unique optical and electronic properties. The ability to fine-tune the structure of these polymers through controlled polymerization reactions opens up new possibilities for developing advanced materials for optoelectronic devices and sensors.
In conclusion, 2,5-dichloropyrimidine-4-carbaldehyde (CAS No. 1803728-57-5) is a multifaceted compound with significant potential in various scientific disciplines. Its unique chemical structure and reactivity make it an invaluable intermediate in organic synthesis and drug discovery. Ongoing research continues to uncover new applications and optimize synthetic methods, further solidifying its importance in the field.
1803728-57-5 (2,5-Dichloropyrimidine-4-carbaldehyde) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)